Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Ying Chieh Wang |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics / Chao Cheng Lin en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 6 (Diciembre)
[artículo]
Título : Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics Tipo de documento: texto impreso Autores: Chao Cheng Lin, Autor ; Ya-Mei Bai, Autor ; Ying Chieh Wang, Autor Fecha de publicación: 2022 Artículo en la página: pp. 29-536 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Peso corporal, Metabólico, Obesidad, Antipsicótico, Amisulprida Resumen: Switching to a different second-generation antipsychotic (SGA) with a lower risk of weight gain is recommended for overweight or obese psychiatric patients undergoing SGA treatment. However, there have been no complete reports regarding the long-term metabolic effects of switching to amisulpride. Link: ./index.php?lvl=notice_display&id=29475
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 6 (Diciembre) . - pp. 29-536[artículo] Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics [texto impreso] / Chao Cheng Lin, Autor ; Ya-Mei Bai, Autor ; Ying Chieh Wang, Autor . - 2022 . - pp. 29-536.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 6 (Diciembre) . - pp. 29-536
Palabras clave: Peso corporal, Metabólico, Obesidad, Antipsicótico, Amisulprida Resumen: Switching to a different second-generation antipsychotic (SGA) with a lower risk of weight gain is recommended for overweight or obese psychiatric patients undergoing SGA treatment. However, there have been no complete reports regarding the long-term metabolic effects of switching to amisulpride. Link: ./index.php?lvl=notice_display&id=29475